Effects of electromagnetic fields on the levels of biogenic amine metabolites, quinolinic acid, and β-endorphin in the cerebrospinal fluid of dairy cows

Neurochemical Research

Volumn 23, Issue 12, 1998, Pages 1527-1531

  Burchard, J F ^a   Nguyen, D H ^b   Richard, L ^b   Young, S N ^c   Heyes, M P ^d   Block, E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HYDRO QUÉBEC   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

3 methoxy 4; 5 hydroxyindoleacetic acid; Biogenic amines; Cows; Electric field; Homovanillic acid; Hydroxyphenylethylene glycol; Magnetic field; Quinolinic acid; Tryptophan; endorphin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; BETA ENDORPHIN; BIOGENIC AMINE; HOMOVANILLIC ACID; QUINOLINIC ACID; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONTROLLED STUDY; COW; ELECTROMAGNETIC FIELD; FEMALE; LIGHT DARK CYCLE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031768439     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020975903631     Document Type: Article

References (27)

1. Seegal, R. F., Wolpaw, J. R., and Dowman, R. 1989. Chronic exposure of primates to 60-Hz electric and magnetic fields: II. Neurochemical effects. Bioelectromagnetics 10:289-301.
2. Vasquez, B. J., Anderson, L. E., Lowery, C. I., and Adey, W. R. 1988. Diurnal patterns in brain biogenic amines of rats exposed to 60-Hz electric fields. Bioelectromagnetics 9:229-236.
3. Reiter, R. J. 1993. Static and extremely low frequency electromagnetic field exposure: reported effects on the circadian production of melatonin. J. Cell. Biochem. 51:394-403.
4. Margonato, V., Nicolini, P., Conti, R., Zecca, L., Veicsteinas, A., and Cerretelli, P. 1995. Biologic effects of prolonged exposure to ELF electromagnetic fields in rats: II. 50 Hz magnetic fields. Bioelectromagnetics 16:343-355.
5. Wolpaw, J. R., Seegal, R. F., and Dowman, R. 1989. Chronic exposure of primates to 60-Hz electric and magnetic fields: I. Exposure system and measurements of general health and performance. Bioelectromagnetics 10:277-288.
6. Dowman, R., Wolpaw, J. R., Seegal, R. F., and Satya-Murti, S. 1989. Chronic exposure of primates to 60-Hz electric and magnetic fields: III. Neurophysiologic effects. Bioelectromagnetics 10: 303-317.
7. Kavaliers, M., Ossenkopp, K. P., and Hirst, M. 1984. Magnetic fields abolish the enhanced nocturnal analgesic response to morphine in mice. Physiol. Behav. 32:261-264.
8. Kavaliers, M. and Ossenkopp, K. P. 1986. Magnetic field inhibition of morphine-induced analgesia and behavioral activity in mice: evidence for involvement of calcium ions. Brain Res. 379: 30-38.
9. Teskey, G. C., Prato, F. S., Ossenkopp, K. P., and Kavaliers, M. 1988. Exposure to time varying magnetic fields associated with magnetic resonance imaging reduces fentanyl-induced analgesia in mice. Bioelectromagnetics 9:167-174.
10. Ossenkopp, K. P. and Kavaliers, M. 1987. Morphine-induced analgesia and exposure to low-intensity 60-Hz magnetic fields: inhibition of nocturnal analgesia in mice is a function of magnetic field intensity. Brain Res. 418:356-360.
11. Ossenkopp, K. P. and Kavaliers, M. 1989. Clinical and applied aspects of magnetic field exposure: A possible role for the endogenous opioid system. J. Bioelectr. 7:189-208.
12. Quock, R. M., Kouchich, F. J., Ishii, T. K., and Lange, D. G. 1986. Microwave facilitation of methylnaltrexone antagonism of morphine-induced analgesia in mice. J. Bioelectr. 5:35-46.
13. Shivers, R. R., Kavaliers, M., Teskey, G. C., Prato, F. S., and Pelletier, R, M, 1987. Magnetic resonance imaging temporarily alters blood-brain barrier permeability in the rat. Neurosci. Lett. 76:25-31.
14. Prato, F. S., Wills, J. M., Roger, J., Frappier, H., Drost, D. J., Lee, T. Y., Shivers, R. R., and Zabel, P. 1994. Blood-brain barrier permeability in rats is altered by exposure to magnetic fields associated with magnetic resonance imaging at 1.5 T. Microscop. Res. Techn. 27:528-534.
15. Salford, L. G., Brun, A., Sturesson, K., Eberhardt, J. L., and Persson, B. R. 1994. Permeability of the blood-brain barrier induced by 915 MHz electromagnetic radiation, continuous wave and modulated at 8, 16, 50, and 200 Hz. Microscop. Res. Techn. 27: 535-542.
16. Persson, B. R. R., Salford, L. G., Brun, A., Eberhardt, J. L., and Malmgren, L. 1992. Increased permeability of the blood-brain barrier induced by magnetic and electromagnetic fields. Ann. N. Y. Acad. Sci. 649:356-358.
17. Burchard, J. F., Nguyen, D. H., Richard, L., and Block, E. 1996. Biological effects of electric and magnetic fields on productivity of dairy cows. J. Dairy Sci. 79:1549-1554.
18. Basile, A. S., Saito, K., Li, Y., and Heyes, M. P. 1995. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J. Neurochem. 64:2607-2614.
19. National Research Council, 1988. Nutrient Requirements of Dairy Cattle, 6th revised edition. National Academy of Science, Washington, DC,
20. Anderson, G. M., Young, J. G., Cohen, D. J., Shaywitz, B. A., and Batter, D. K. 1981. Amperometric determination of 3-methoxy-4-hydroxyphenylethyleneglycol in human cerebrospinal fluid. J. Chromatogr. 222:112-115.
21. Anderson, G. M., Young, J. G., and Cohen, D. J. 1979. Rapid liquid chromatographic determination of tryptophan, tyrosine, 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid. J. Chromatogr. 164:501-505.
22. Heyes, M. P., Saito, K., and Markey, S. P. 1992. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283:633-635.
23. Garelis, E., Young, S. N., Lal, S., and Sourkes, T. L. 1974. Monoamine metabolites in lumbar CSF: their sites of origin in relation to clinical studies. Brain Res. 79:1-8.
24. Bertilsson, L. 1987. 5-Hydroxyindoleacetic acid in cerebrospinal fluid: methodological and clinical aspects. Life Sci. 41:821-824.
25. Leibowitz, S. F., Weiss, G. F., and Shor-Posner, G. 1988. Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action. Clin. Neuropharmacol. 11 Supplement 1:S51-S71.
26. Heyes, M. P., Saito, K., Crowley, J. S., Davis, L. E., Demitrack, M. A., Der, M., Dilling, L. A., Elia, J., Kruesi, M. J. P., Lackner, A., Larsen, S. A., Lee, K., Leonard, H. L., Markey, S. P., Martin, A., Milstein, S., Mouradian, M. M., Pranzatelli, M. R., Quearry, B. J., Salazar, A., Smith, M., Strauss, S. E., Sunderland, T., Swedo, S. W., and Tourtellotte, W. W. 1992. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249-1273.
27. Burchard, J. F., Nguyen, D. H., Richard, L., and Block, E. 1997. Electric and magnetic fields and minerals in cows. J. Dairy Sci. in press: